Global private equity player Sequoia Capital has invested Rs 100 crore in Hyderabad-based contract research organisation GVK Biosciences. The investment comes close on the heels of Sequoia picking up an 18% stake in Hyderabad-based CRO SAI Advantium, signaling the PE major’s interest in the contract research space. GVK Biosciences plans to use the money to fund acquisitions in the CRO space and also add to its existing capacities. “We are looking at targets both in India and abroad for expanding our work. Low-cost destinations are not a priority for us because we are open to making acquisitions even in the US and Europe,” GVK Bio president Manni Kantipudi told ET. According to him, the acquisitions would be made to compliment the company’s existing activities in the pre-clinical and clinical research areas. […]